
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")
("Wishbone" or the "Company")
Application for
The exercise price of the warrants is 12p per share. An acceleration clause allowed the Company to require exercise of the warrants if the shares closed above 16p for five out of 10 trading days. The shares closed above 16p from
When issued, the Ordinary Shares under the block listing will rank pari passu with the Company's existing issued Ordinary Shares. It is expected that admission will become effective on or around
For further information, please contact:
|
|
Richard Poulden, Chairman |
Tel: +971 45 846 284 |
|
|
|
|
(Nominated Adviser and AQUIS Exchange Corporate Adviser) |
|
|
Tel: +44 20 7628 3396 |
|
|
|
|
(Broker) |
|
|
Tel: +44 20 7469 0930 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the